Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Z08:GR

1.207 EUR 0.007 0.58%

As of 06:46:23 ET on 05/22/2015.

Snapshot for Zogenix Inc (Z08)

Open: 1.211 Day's Range: 1.207 - 1.233 Volume: 0
Previous Close: 1.214 52wk Range: 0.827 - 1.921 1-Yr Rtn: -12.54%

Stock Chart for Z08

No chart data available.
  • Z08:GR 1.233
  • 1D
  • 1M
  • 1Y
1.214
Interactive Z08 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for Z08

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.3920
Est. PEG Ratio -
Market Cap (M EUR) 185.11
Shares Outstanding (M) 153.36
30 Day Average Volume 663
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for Z08

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for Z08

Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.

Stephen J FarrCEO/Co-FounderAnn D RhoadsExec VP/CFO/Treasurer/Secy
Bradley Stuart Galer "Brad Gale"Exec VP/Chief Medical OfficerJohn J TuraninVP & General Mgr:Zogenix Tech
More Company Profile & Key Executives for Z08

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil